BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19758672)

  • 21. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early gastric and superficial muscle gastric cancer. Contribution of morphology to prognosis].
    Moral Moral G; Velasco Osés A; Seco Gil J; Bengoechea Beeby MP
    Rev Esp Enferm Dig; 1993 May; 83(5):325-31. PubMed ID: 8318274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic characteristics and prognosis of gastric cancer invading the subserosa.
    Jiang CG; Wang ZN; Sun Z; Liu FN; Yu M; Xu HM
    J Surg Oncol; 2010 Dec; 102(7):737-41. PubMed ID: 21104924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological study of depth of subserosal invasion in patients with pT2 gallbladder carcinoma.
    Sasaki R; Uesugi N; Itabashi H; Fujita T; Takeda Y; Hoshikawa K; Takahashi M; Funato O; Nitta H; Sugai T; Kanno S; Saito K
    J Surg Oncol; 2005 Nov; 92(2):83-8. PubMed ID: 16231372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival predictors in patients with node-negative gastric carcinoma.
    Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
    Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
    Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses.
    Adachi Y; Mori M; Maehara Y; Kitano S; Sugimachi K
    J Am Coll Surg; 1997 Apr; 184(4):373-7. PubMed ID: 9100682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic studies on gastric cancer with concomitant liver metastases.
    Fujisaki S; Tomita R; Nezu T; Kimizuka K; Park E; Fukuzawa M
    Hepatogastroenterology; 2001; 48(39):892-4. PubMed ID: 11462950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of splenectomy on advanced proximal gastric cancer with No. 10 lymph node metastasis.
    Huang CM; Wang JB; Lu HS; Zheng CH; Li P; Xie JW; Zhang XF
    Chin Med J (Engl); 2009 Nov; 122(22):2757-62. PubMed ID: 19951610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment for advanced gastric cancer.
    Maekawa S; Saku M; Maehara Y; Sadanaga N; Ikejiri K; Anai H; Kuwano H; Sugimachi K
    Hepatogastroenterology; 1996; 43(7):178-86. PubMed ID: 8682459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of prognostic factors in surgery of gastric cancer].
    Cavallaro A; Agresta F; Rizzo S; Di Giovanni V
    G Chir; 1989 Mar; 10(3):88-92. PubMed ID: 2518543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor diameter as a prognostic factor in patients with gastric cancer.
    Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Kosaka T; Ono HA; Otsuka Y; Akiyama H; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Jul; 15(7):1959-67. PubMed ID: 18369676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
    Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
    Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors in stomach cancer: invasion of gastric serosa and lymph node involvement].
    Belcastro G; Nicolanti V; Ferri M; Chiavellati L; Fratticioli C; Schillaci A
    Minerva Chir; 1990 Oct; 45(20):1287-91. PubMed ID: 2082206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric carcinoma confined to the muscularis propria: how can we detect, evaluate, and cure intermediate-stage carcinoma of the stomach?
    Nakamura K; Kamei T; Ohtomo N; Kinukawa N; Tanaka M
    Am J Gastroenterol; 1999 Aug; 94(8):2251-5. PubMed ID: 10445558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.